ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 950,17
0,11%
Dow Jones
44 544,66
-0,75%
DAX
21 732,05
0,01%
Brent Oil
76,385
0,00%
Bitcoin
99 367,99
-1,29%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. Lucid Diagnostics Inc (LUCD) Cours

Lucid Diagnostics Inc

Lucid Diagnostics Inc (LUCD)

NASDAQ
0,9579
0,034
(3,68%)
Fermé 02 Février 10:00PM
Retardé de 15 minutes
0,9615
0,0036
(0,38%)
Après les heures de négociation: 1:57AM
Retardé de 15 minutes

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Premium

Statistiques et détails clés

Dernier
0,9615
Prix Achat
0,85
Prix Vente
1,00
Volume échangé
390 466
0,9188 Fourchette du Jour 0,9609
0,6301 Plage de 52 semaines 1,50
Cap du marché
57,058M
Clôture Veille
0,9239
Ouverture
0,9299
Dernière Transaction
100
@
0.9615
(formt)
Dernière heure de transaction
Volume financier
US$ 371 289
VWAP
0,950887
Volume moyen (3 m)
452 910
Actions en circulation
59 342 479
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-1,08
Bénéfice par action (BPA)
-0,89
Chiffre d'affairess
2,43M
Bénéfice net
-52,67M

À propos de Lucid Diagnostics Inc

Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease, also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically hig... Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease, also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard. Show more

Secteur
Surgical,med Instr,apparatus
Industrie
Surgical,med Instr,apparatus
Siège social
Wilmington, Delaware, USA
Fondé
-
Lucid Diagnostics Inc est coté dans le secteur Surgical,med Instr,apparatus de la NASDAQ avec le ticker LUCD. Le dernier cours de clôture d'Lucid Diagnostics était de US$0,92. Au cours de la dernière année, les actions de Lucid Diagnostics ont été négociées dans une fourchette de prix de US$ 0,6301 à US$ 1,50.

Lucid Diagnostics compte actuellement 59 342 479 actions en circulation. La capitalisation boursière d'Lucid Diagnostics est de US$54,83 million. Lucid Diagnostics a un ratio cours/bénéfice (ratio PE) de -1.08.

LUCD Dernières nouvelles

Plus de nouvelles

Form S-8 - Securities to be offered to employees in employee benefit plans

31 Janvier 2025
Edgar (US Regulatory)

Form S-8 - Securities to be offered to employees in employee benefit plans

31 Janvier 2025
Edgar (US Regulatory)

Lucid Diagnostics Announces Record Quarterly EsoGuard® Test Volume

Lucid Diagnostics Announces Record Quarterly EsoGuard® Test Volume PR Newswire NEW YORK, Jan. 13, 2025 Quarterly test volume of over 4,000 tests represented sequential increase of 45 percent NEW...

13 Janvier 2025
PR Newswire (US)

Lucid Diagnostics Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule

Lucid Diagnostics Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule PR Newswire NEW YORK, Dec. 23, 2024 NEW YORK, Dec. 23, 2024 /PRNewswire/ -- Lucid...

23 Décembre 2024
PR Newswire (US)

Form 8-K - Current report

20 Décembre 2024
Edgar (US Regulatory)

Lucid Diagnostics Partners with VITALExam to Enhance Esophageal Precancer Detection for Firefighters

Lucid Diagnostics Partners with VITALExam to Enhance Esophageal Precancer Detection for Firefighters PR Newswire NEW YORK, Dec. 19, 2024 Partnership launched with fully-contracted...

19 Décembre 2024
PR Newswire (US)

Prospective Clinical Utility Study of Lucid Diagnostics' EsoGuard® Esophageal DNA Test Accepted for Peer-Reviewed Publication

Prospective Clinical Utility Study of Lucid Diagnostics' EsoGuard® Esophageal DNA Test Accepted for Peer-Reviewed Publication PR Newswire NEW YORK, Dec. 11, 2024 Study demonstrates outstanding...

11 Décembre 2024
PR Newswire (US)

Form D - Notice of Exempt Offering of Securities

06 Décembre 2024
Edgar (US Regulatory)

Lucid Diagnostics Completes Convertible Debt Refinancing to Strengthen Balance Sheet and Extend Cash Runway Past Key Near-Term Milestones

Lucid Diagnostics Completes Convertible Debt Refinancing to Strengthen Balance Sheet and Extend Cash Runway Past Key Near-Term Milestones PR Newswire NEW YORK, Dec. 3, 2024 New convertible debt...

03 Décembre 2024
PR Newswire (US)

Form 8-K - Current report

29 Novembre 2024
Edgar (US Regulatory)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10.104512.19369894980.8570.9690.8422292453300.90535535CS
40.131515.8433734940.830.9690.78032066830.86688777CS
12-0.0385-3.8511.120.75014529100.89690682CS
260.161520.18750.81.120.72013188120.88160361CS
52-0.5385-35.91.51.50.63012490300.90230439CS
156-2.0385-67.9534.05980.63011385821.37880358CS
260-11.7885-92.458823529412.7513.50.63011549912.52109956CS

LUCD - Frequently Asked Questions (FAQ)

What is the current Lucid Diagnostics share price?
The current share price of Lucid Diagnostics is US$ 0,9615
How many Lucid Diagnostics shares are in issue?
Lucid Diagnostics has 59 342 479 shares in issue
What is the market cap of Lucid Diagnostics?
The market capitalisation of Lucid Diagnostics is USD 54,83M
What is the 1 year trading range for Lucid Diagnostics share price?
Lucid Diagnostics has traded in the range of US$ 0,6301 to US$ 1,50 during the past year
What is the PE ratio of Lucid Diagnostics?
The price to earnings ratio of Lucid Diagnostics is -1,08
What is the cash to sales ratio of Lucid Diagnostics?
The cash to sales ratio of Lucid Diagnostics is 23,47
What is the reporting currency for Lucid Diagnostics?
Lucid Diagnostics reports financial results in USD
What is the latest annual turnover for Lucid Diagnostics?
The latest annual turnover of Lucid Diagnostics is USD 2,43M
What is the latest annual profit for Lucid Diagnostics?
The latest annual profit of Lucid Diagnostics is USD -52,67M
What is the registered address of Lucid Diagnostics?
The registered address for Lucid Diagnostics is CORPORATION TRUST CENTER 1209 ORANGE ST, WILMINGTON, DELAWARE, 19801
Which industry sector does Lucid Diagnostics operate in?
Lucid Diagnostics operates in the SURGICAL,MED INSTR,APPARATUS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
TCTMTCTM Kids IT Education Inc
US$ 0,764
(321,87%)
729,72M
REBNReborn Coffee Inc
US$ 3,31
(63,05%)
55,54M
FCUVFocus Universal Inc
US$ 5,87
(56,62%)
1,73M
SOPASociety Pass Inc
US$ 1,54
(56,50%)
13,82M
CYCNCyclerion Therapeutics Inc
US$ 3,92
(54,33%)
82,39M
ENVBEnveric Biosciences Inc
US$ 2,0899
(-46,41%)
1,57M
NIVFNewGenIvf Group Ltd
US$ 0,1489
(-42,51%)
14,8M
GLSTGlobal Star Acquisition Inc
US$ 8,83
(-39,10%)
23,89k
PRPHProPhase Labs Inc
US$ 0,2633
(-38,02%)
872,46k
SPGCSacks Parente Golf Inc
US$ 0,5601
(-37,86%)
7,27M
TCTMTCTM Kids IT Education Inc
US$ 0,764
(321,87%)
731,1M
NVDANVIDIA Corporation
US$ 120,07
(-3,67%)
388,5M
RIMEAlgorhythm Holdings Inc
US$ 0,02565
(5,12%)
341,8M
CLEUChina Liberal Education Holdings Ltd
US$ 0,1938
(30,77%)
237,15M
BHATBlue Hat Interactive Entertainment Technology
US$ 0,0355
(-11,25%)
236,44M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
LUCD
Lucid Diagnostics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces